Use of 1,2-dimethyl-3-fluoro-, 1-methyl-3,3-difluoro-, and 1,2-d

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2603265B, 204158R, C07D20952, A01N 4338

Patent

active

043495648

ABSTRACT:
Cyclobutanecarboxylic acid imides of the formula I ##STR1## wherein one of R.sub.1 and R.sub.6 is hydrogen, methyl or ethyl, and the other is methyl or ethyl, R.sub.2 and R.sub.3 independently of one another are each hydrogen, fluorine or methyl, or R.sub.2 is acetoxy or chlorine while R.sub.3 is hydrogen, and wherein R.sub.4 is hydrogen, methyl or chlorine, and R.sub.5 is hydrogen or methyl, whereby R.sub.3 and R.sub.4 together can also form an additional bond in the four-membered ring, are suitable for combating various fungi and have a particularly excellent action against Botrytis. They can be produced in an especially advantageous manner by photochemical [2+2] cycloaddition of alkenes or alkynes with for example appropriately substituted maleic acid-(3,5-dichlorophenyl)imides.

REFERENCES:
patent: 3549655 (1970-12-01), Bublitz

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of 1,2-dimethyl-3-fluoro-, 1-methyl-3,3-difluoro-, and 1,2-d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 1,2-dimethyl-3-fluoro-, 1-methyl-3,3-difluoro-, and 1,2-d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1,2-dimethyl-3-fluoro-, 1-methyl-3,3-difluoro-, and 1,2-d will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2154980

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.